Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of "Bamboo" and Other Vocal Cord Lesions Responsible for Dysphonia in Patients With Systemic Autoimmune Diseases.

NCT06779799 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT06779799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06779799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of "Bamboo" and Other Vocal Cord Lesions Responsible for Dysphonia in Patients With Systemic Autoimmune Diseases.
Lead sponsor
University Hospital, Brest
Phase
Observational
Overall status
Recruiting
Start date
December 1, 2024
Completion date
May 31, 2025
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

connective tissue disease, dysphonia, vasculitis